A detailed history of Ridgewood Investments LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Ridgewood Investments LLC holds 24 shares of MYGN stock, worth $329. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24
Previous 101 76.24%
Holding current value
$329
Previous $2,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$23.97 - $28.6 $1,845 - $2,202
-77 Reduced 76.24%
24 $0
Q2 2024

Jul 29, 2024

BUY
$17.98 - $25.47 $1,815 - $2,572
101 New
101 $2,000
Q1 2023

Apr 25, 2023

BUY
$15.26 - $23.75 $1,541 - $2,398
101 New
101 $2,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.11B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Ridgewood Investments LLC Portfolio

Follow Ridgewood Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ridgewood Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ridgewood Investments LLC with notifications on news.